Arthur Kuan
Chief Executive Officer at CG Oncology Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: CG Oncology Inc., 2 years.
CG Oncology Inc.
Director · Chief Executive Officer
Chief executive roles
CG Oncology Inc.
· Chief Executive Officer
Since January 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | CG Oncology Inc. | Option exercise | +64,612 | $1.72 | $111,133 |
| Mar 12, 2026 | CG Oncology Inc. | Shares withheld for tax | −1,847 | $60.15 | $111,097 |
| Mar 4, 2026 | CG Oncology Inc. | Option exercise | +102,871 | $1.72 | $176,938 |
| Mar 4, 2026 | CG Oncology Inc. | Shares withheld for tax | −2,871 | $61.61 | $176,882 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.